FREE CONSULTING
1st step
DOCTOR VISIT
2st step
GET STARTED
3st step

Sermorelin therapy

Unfortunatelly, as we age, the level of Human Growth Hormone in our bodies can decline, causing some age-related conditions and diseases. There are enough various kinds of different drugs and supplements which doctors recommend using in case they find not sufficient levels of HGH in adults, some of them are strong and may have hard side-effects, some are completely safe and bring many benefits to your health. Anti-Aging experts use injections of peptides as Sermorelin, GHRP-2 and GHRP-6 to fight this problem. Also the use of Sermorelin can affect your appearance making you look significantly younger.

Sermorelin Therapy before and after

If you have deficiency of Human Growth Hormone (somatotropin), in addition to recombinant hormone, specialists can prescribe you taking recombinant somatoliberin - sermorelin; it is approved by the FDA for the treatment of adult somatropin deficiency and has earned many good recommendations. Sermorelin is an N-terminal fragment of human somatoliberin, consisting of 29 amino acid residues (there are 44 in somatoliberin) and having the same biological activity as native somatoliberin. Sermorelin is generally well tolerated and cheaper than somatropin itself, but in clinical trials it has been shown to be somewhat less effective at recommended doses. In addition, sermorelin is ineffective in the defeat of the adenohypophysis. Therefore, before starting treatment, it is necessary to make sure that the level of Human Growth Hormone increases to at least 2 mcg/l in response to the introduction of a trial dose of sermorelin. Subsequently, sermorelin is injected at a dose of 30 mcg/kg/day n/a.

To reach the effectiveness of treatment, it is necessary to regularly measure the patient's height. Doctors also use Sermorelin for diagnostic purposes for the differential diagnosis of the hypothalamus and pituitary gland lesions, but the clinical significance of the sample with sermorelin has not been established yet.

Find out more